Skip to main content

Advertisement

Table 2 Baseline characteristics of groups with increase or decrease of eGFR after treatment

From: Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy

Characteristic Total (n = 81) T2T1GFRRatio > 1
Yes(n = 50) No(n = 31) p
Age, yr 41.8 ± 12.1 41.3 ± 11.1 42.6 ± 13.8 0.815
Male, n(%) 34(42.0) 24(48.0) 10(32.3) 0.244
Serum Creatinine, μmol/L 101.1 ± 56.0 100.2 ± 47.9 102.5 ± 67.9 0.431
Albumin, g/L 40.4 ± 5.0 40.8 ± 5.3 39.7 ± 4.4 0.288
24 h Proteinuria, g 1.3 ± 1.3 1.2 ± 1.3 1.5 ± 1.3 0.133
eGFR, mL/min/1.73m2 81.7 ± 33.4 81.6 ± 30.4 82.0 ± 38.3 0.760
  1. Data are mean ± standard deviation, n(%)